Nav: Home

How common are mental health disorders after diagnosis of head and neck cancer?

February 28, 2019

BottomLine: Treatment for head and neck cancer (HNC) might cure the disease but it also can result in adverse effects such as disfigurement and speech difficulties, which can affect quality of life for patients. Using information from a large insurance claims database, this study examined how common mental health disorders were in patients with HNC and how they were associated with diagnosis and treatment. The study included nearly 53,000 patients with HNC and researchers report the proportion of mental health disorders was 29.9 percent, an increase from 20.6 percent before the cancer diagnosis. Women and patients with a history of tobacco use and alcohol use were more likely to develop mental health disorders. The study may have underestimated how common mental health disorders were among the patients. Researchers suggest patients with HNC be monitored for mental health disorders.

Authors: Neerav Goyal, M.D., M.P.H., Pennsylvania State University, Hershey, and coauthors

(doi:10.1001/jamaoto.2018.4512)

Editor's Note: The article includes conflict of interest disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.
-end-
Want to embed a link to this study in your story? This full-text link will be live at the embargo time https://jamanetwork.com/journals/jamaotolaryngology/fullarticle/2726020?guestAccessKey=0459f2e9-2a21-41bd-afa6-a865d75088cf&utm_source=JAMA Network&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=022819

JAMA Otolaryngology - Head & Neck Surgery

Related Neck Cancer Articles:

Immunotherapy kinder than chemotherapy for patients with head and neck cancer
The immunotherapy nivolumab is kinder than chemotherapy for people with advanced head and neck cancer -- easing many of the negative effects of the disease on patients' quality of life.
Head & neck cancer recurrence following radiation associated with high tumor PD-L1 expression
Recurrence of head and neck squamous cell carcinoma (HNSCC) negative for human papillomavirus (HPV) following radiation therapy was associated with high tumor levels of the protein PD-L1.
Twice-daily radiation therapy cuts deaths from head and neck cancer
Treating head and neck cancer patients with a twice-daily radiation therapy combined with chemotherapy could save more lives.
Blood-borne HPV antibodies indicate head, neck cancer prognosis
A new study in JAMA Oncology finds that the presence of particular antibodies of human papillomavirus in blood serum are reliable indicators of five-year head and neck cancer survival.
I get by with help from my friends: Maintaining immune cells in head and neck cancer
In an article published Sept. 22, 2016 in Frontiers in Immunology, researchers at the Medical University of South Carolina and the Ralph H.
Nivolumab reduces symptoms in relapsed metastatic head and neck cancer
Nivolumab maintains function and reduces symptoms in treatment of relapsed metastatic head and neck cancer, according to results from the CheckMate 141 trial presented at the ESMO 2016 Congress in Copenhagen1 and published in the New England Journal of Medicine.
Nivolumab reduces symptoms in relapsed metastatic head and neck cancer
Nivolumab maintains function and reduces symptoms in treatment of relapsed metastatic head and neck cancer, according to results from the CheckMate 141 trial presented at the ESMO 2016 Congress in Copenhagen1 and published in the New England Journal of Medicine.
'Game-changing' immunotherapy doubles head and neck cancer survival
An immunotherapy drug has been hailed as a potential 'game changer' after being found to greatly improve survival for patients with relapsed head and neck cancer -- a disease which is notoriously difficult to treat.
True burden of head and neck cancer in France underestimated by more than one-third
A nationwide study of head and neck cancers in France has revealed that the true burden of the disease is underestimated by at least one-third, and that head and neck cancers carry a very high risk of secondary primary cancers, according to two presentations at the ESMO 2016 Congress in Copenhagen.
Type 2 diabetes drug could be beneficial for head and neck cancer patients
Researchers at the University of Cincinnati College of Medicine have found that adding increasing doses of an approved Type 2 diabetes drug, metformin, to a chemotherapy and radiation treatment regimen in head and neck cancer patients is not well tolerated if escalated too quickly, but allowing slower escalation could be beneficial.

Related Neck Cancer Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Changing The World
What does it take to change the world for the better? This hour, TED speakers explore ideas on activism—what motivates it, why it matters, and how each of us can make a difference. Guests include civil rights activist Ruby Sales, labor leader and civil rights activist Dolores Huerta, author Jeremy Heimans, "craftivist" Sarah Corbett, and designer and futurist Angela Oguntala.
Now Playing: Science for the People

#520 A Closer Look at Objectivism
This week we broach the topic of Objectivism. We'll be speaking with Keith Lockitch, senior fellow at the Ayn Rand Institute, about the philosophy of Objectivism as it's taught through Ayn Rand's writings. Then we'll speak with Denise Cummins, cognitive scientist, author and fellow at the Association for Psychological Science, about the impact of Objectivist ideology on society. Related links: This is what happens when you take Ayn Rand seriously Another Critic Who Doesn’t Care What Rand Thought or Why She Thought It, Only That She’s Wrong Quote is from "A Companion to Ayn Rand"